Research Topics
Genomes and Genes | S D FossaSummaryAffiliation: University of Oslo Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional studyJan Oldenburg
Department of Clinical Cancer Research, The Norwegian Radiumhospital, Oslo, Norway
J Transl Med 5:70. 2007..To assess the impact of polymorphisms in Glutathione S-transferase (GST) -P1, -M1, and -T1 on self-reported chemotherapy-induced long-term toxicities in testicular cancer survivors (TCSs)...
Health-related quality of life in patients treated for testicular cancerS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
Curr Opin Urol 9:425-9. 1999..The long-term investigation and follow-up of testicular cancer survivors provide useful information on survivorship problems in cured cancer patients in general...
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsyS D Fossa
Department of Clinical Research, The Norwegian Radium Hospital, Oslo, Norway
Ann Oncol 14:1412-8. 2003....
Fatigue, anxiety, and depression in long-term survivors of testicular cancerSophie D Fossa
Norwegian Radium Hospital, Department of Oncology and Radiotherapy, Oslo, Norway
J Clin Oncol 21:1249-54. 2003..Occurrence of CF in TCSs is compared with findings in male survivors of Hodgkin's disease (HDSs) and in males from the general population (GenPop)...
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)Sophie D Fossa
Norwegian Radium Hospital, Oslo, Norway
J Clin Oncol 21:1107-18. 2003..To describe global quality of life (GLQL) in patients with metastatic testicular cancer (TC) treated with four different schedules of bleomycin, etoposide, and cisplatin (BEP) chemotherapy (four v three cycles given over 5 v 3 days)...
Selection of patients may limit the generalizability of results from cancer trialsSophie D Fossa
Norwegian Radium Hospital, University of Oslo
Acta Oncol 41:131-7. 2002..By registering patients undergoing comparable treatment outside a trial, the overall applicability of the treatment in question can be assessed...
Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893S D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
Eur Urol 37:541-51. 2000..To compare the quality of life (QL) of patients with poor prognosis M1 prostate cancer treated with orchiectomy alone (ORCH) or orchiectomy combined with adjuvant mitomycin C (MMC; 15 mg/m(2) i.v. q 6 weeks: ORCH+MMC; EORTC trial 30893)...
Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be consideredSophie D Fossa
Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Montebello, Oslo
Scand J Urol Nephrol 36:34-9. 2002..The formulation may therefore be beneficial in anthracycline-sensitive malignancies, where toxicity represents a major problem, as is the case in androgen-insensitive prostate cancer (AIPC)...
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
J Clin Oncol 19:62-71. 2001....
No randomised trial of prostate-cancer screening in NorwayS D Fossa
Norwegian Radium Hospital, Oslo
Lancet Oncol 2:741-5; discussion 746-9. 2001..In this review, the NUCG's reasons for not participating in the trial are discussed in full...
Long-term renal function after treatment for malignant germ-cell tumoursS D Fossa
Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
Ann Oncol 13:222-8. 2002....
Increased mortality rates in young and middle-aged patients with malignant germ cell tumoursS D Fossa
The Norwegian Radium Hospital, Department of Clinical Research, Montebello, N 0310 Oslo, Norway
Br J Cancer 90:607-12. 2004..The increased death risk due to benign gastrointestinal disorders, probably related to radiotherapy, requires future in-depth analysis...
Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancerS D Fossa
Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, 0310, Oslo, Norway
J Psychosom Res 52:79-87. 2002....
Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancerSophie D Fossa
Norwegian Radium Hospital, Department of Clinical Cancer Research, Montebello, Oslo, Norway
Acta Oncol 43:134-41. 2004..Knowledge of post-treatment long-term morbidity is essential for early recognition and treatment of late complications, and enables adequate counselling of new cancer patients...
Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomySophie D Fossa
Department of Clinical Research, The Norwegian Radium Hospital, Oslo, Norway
Int J Radiat Oncol Biol Phys 57:33-41. 2003..To evaluate the postradiotherapy 5-year cancer-specific (CSS), clinical progression-free (cPFS), and overall (OS) survival rates in patients with pN0 M0 prostate cancer (PC)...
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)S D Fossa
Department of Oncology, Norwegian Radium Hospital, University of Oslo, Oslo, Norway
Br J Cancer 93:1209-14. 2005..The treatment's toxicity is manageable in a multicentre setting. In poor prognosis patients, C-BOP/BEP should be compared to standard chemotherapy of four cycles of BEP...
Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinomaSophie D Fossa
Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway
Cancer 101:533-40. 2004..In 1995, preclinical and clinical data indicated an improvement of these results if IFN was combined with 13-cis retinoic acid (CRA)...
[Are all LH-RH analogues equally effective in prostate cancer?]Sophie D Fossa
Fagområdet Klinisk kreftforskning, Enhet for langtidsstudier, Rikshospitalet Radiumhospitalet, 0310 Oslo
Tidsskr Nor Laegeforen 125:2493-5. 2005..The diagnosis of "hormone resistant prostate cancer" requires that the patient's serum testosterone is measured within the range corresponding to surgical castration...
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]Sophie D Fossa
Det norske radiumhospital HF, Montebello, 0310 Oslo
Tidsskr Nor Laegeforen 125:41-4. 2005..Cancer survivors have an increased risk of life-long health problems that may be associated with their treatment...
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivorsH S Haugnes
Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
J Cancer Surviv 2:128-37. 2008....
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective studyB B Herlofson
Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Norway
Eur J Oral Sci 105:523-6. 1997..The study revealed that 62% of the patients in the chemotherapy group developed adverse soft tissue reactions, with mucositis and pain as chief complaints, whereas none in the control group experienced any mucosal complications...
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?S D Fossa
Department of Medical Oncology, Norwegian Radium Hospital, Oslo
Br J Cancer 70:1156-60. 1994..The responsible cancer centre and the local hospitals should establish a high degree of cooperation and enable adequate follow-up examinations in these patients...
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working GroupS D Fossa
Norwegian Radium Hospital, Oslo, Norway
J Clin Oncol 17:1146. 1999..To compare relapse rates and toxicity associated with para-aortic (PA) strip or PA and ipsilateral iliac lymph node irradiation (dogleg [DL] field) (30 Gy/15 fractions/3 weeks) for stage I testicular seminoma...
Risk of cancer in relatives of testicular cancer patientsK Heimdal
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Br J Cancer 73:970-3. 1996..This study supports the hypothesis that families of testicular cancer patients are not prone to cancer...
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancerS D Fossa
Department of Medical Oncology, Norwegian Radium Hospital, Oslo
Br J Cancer 66:181-4. 1992..The lack of serum PSA to predict survival may be explained by a heterogenous composition of hormone resistant prostate cancer as regards differentiated and/or PSA producing vs undifferentiated and/or PSA non-producing cells...
Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group studyL H Aksnes
Department of Oncology, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
Pediatr Blood Cancer 53:84-9. 2009..The results were compared with findings in age- and gender-matched individuals from the general population (NORMs)...
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancerW Lilleby
Department of Oncology and Radiotherapy, Norwegian Radium Hospital, N 0310 Oslo, Norway
Prostate 46:126-33. 2001..We evaluated the additional prognostic impact of serum levels of neuron-specific enolase (NSE) and chromograninA (CgA) after curative radiotherapy and the importance of serum PSA, analyzed 3 months after irradiation...
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivorsH Landmark-Høyvik
Department of Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo 310, Norway
Pharmacogenomics J 9:333-40. 2009....
Interest and preferences for exercise counselling and programming among Norwegian cancer survivorsG M Gjerset
Department of Clinical Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Eur J Cancer Care (Engl) 20:96-105. 2011..The knowledge from this study can contribute to make suitable physical rehabilitation available to cancer patients in the future...
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladderA Berner
Department of Pathology, Norwegian Radium Hospital, Oslo
Histopathology 22:327-33. 1993..004). Whether the c-erbB-2 expression is a useful prognostic marker in addition to other conventional parameters, remains to be shown...
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapyC E Kiserud
Department of Clinical Cancer Research, National Resource Center for long term effects after Cancer, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo 0310, Norway
Br J Cancer 100:455-63. 2009....
Components of the metabolic syndrome in long-term survivors of testicular cancerH S Haugnes
Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Norway
Ann Oncol 18:241-8. 2007..A possible explanation of the excess cardiovascular risk in testicular cancer (TC) survivors is development of metabolic syndrome. The association between metabolic syndrome and TC treatment is examined in long-term survivors...
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal studyT Wethal
Department of Cardiology, University of Oslo, Sognsvannsveien 20, Oslo 0027, Norway
Br J Cancer 101:575-81. 2009..This study examined the time-dependent development and evolution of valvular and myocardial function related to treatment with mediastinal radiotherapy and anthracyclines in HLSs...
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party,S D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
J Clin Oncol 16:716-24. 1998..To determine the effect of r-metHu granulocyte colony-stimulating factor (G-CSF) on the proportion of patients with metastatic poor-prognosis malignant germ cell tumors who receive full dose-intensity combination chemotherapy...
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancerT Wethal
Department of Cardiology, Faculty Division Rikshospitalet, University of Oslo, Oslo, Norway
J Cancer Surviv 1:8-16. 2007..Treatment in testicular cancer survivors (TCSs) may be followed by cardiovascular disorders. We have examined whether today's three treatment modalities are associated with a biochemical cardiovascular risk profile...
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?T Wethal
Department of Cardiology, Faculty Division Rikshospitalet, University of Oslo, Oslo, Norway
Eur J Cancer 46:3425-33. 2010..There is conflicting evidence regarding CRP as a marker of future cancer. We studied whether CRP predicts CVD and consecutive cancer in testicular cancer survivors (TCSs)...
Quality of life in patients with urinary diversion after operation for locally advanced rectal cancerM G Guren
Department of Clinical Cancer Research, The Norwegian Radium Hospital, N 0310 Oslo, Norway
Eur J Surg Oncol 27:645-51. 2001..The aim was to assess the quality of life (QoL) in disease-free patients with urinary diversion after extensive surgery for advanced rectal cancer...
Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthoodH Magelssen
Rikshospitalet Radiumhospitalet Medical Center, Department of Clinical Cancer Research, University of Oslo, Montebello, 0310 Oslo, Norway
Hum Reprod 23:178-86. 2008..To compare first-time parenthood probability and pregnancy outcome between cancer patients and the general population...
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancerS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
Br J Cancer 68:572-8. 1993..A high SPF, determined by FCM, may be helpful to identify patients with chemotherapy-sensitive TCC of the urinary bladder...
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinomaS D Fossa
Department of Medical Oncology, Norwegian Radium Hospital, Oslo
Acta Oncol 29:303-6. 1990..If at least 30% tumour size reduction is observed at that time, the patient will most probably respond objectively. If the size reduction is less, IFN with or without VB is likely to be ineffective in terms of response achievement...
Pain after palliative radiotherapy for spine metastasesO Zaikova
Department of Orthopaedic Surgery, Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway
Clin Oncol (R Coll Radiol) 22:828-36. 2010..The purpose of the study was to evaluate the response to palliative radiotherapy in patients with painful spinal metastatic disease (SMD)...
Survival after curative treatment of muscle-invasive bladder cancerS D Fossa
Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Montebello, Oslo
Acta Oncol 35:59-65. 1996..However, subgroups of patients may benefit from this approach allowing bladder conservation in selected cases. More effective adjuvant regimens have to be developed for high-risk patients (pT3b/pN+)...
Frequent loss of 11p13 and 11p15 loci in male germ cell tumoursR A Lothe
Department of Genetics, Norwegian Radium Hospital, Montebello, Oslo
Genes Chromosomes Cancer 7:96-101. 1993..In addition, identification of the parental origin of the allelic losses revealed a paternal loss in six patients and a maternal loss in one case...
Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancerS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
Br J Urol 62:449-53. 1988....
Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapyA E Kyrdalen
Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Prostate Cancer Prostatic Dis 13:144-50. 2010..Further studies of CF in prostate cancer survivors should take into consideration the survivors' pretreatment medical and psychosocial situation...
Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapyL Thorsen
Department of Psychosocial Oncology and Rehabilitation, The Norwegian Radium Hospital, Oslo, Norway
J Sports Med Phys Fitness 46:122-7. 2006..We hypothesized an association between these parameters, since they might be thought to measure parts of the same phenomenon...
Blood pressure and body mass index in long-term survivors of testicular cancerH Sagstuen
Department of Oncology, Institute of Clinical Medicine, University of Tromsø, N 9037 Tromsø, Norway
J Clin Oncol 23:4980-90. 2005..To evaluate blood pressure and body mass index (BMI) in long-term survivors of testicular cancer (TC) treated with different modalities...
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancerS M Kraggerud
Department of Cell Biology, Norwegian Radium Hospital, Montebello, Oslo, Norway
Pathol Res Pract 193:471-8. 1997..However, FCM is a more sensitive and objective method for the detection of p53 protein than IHC and this should be taken into account when routinely evaluating the p53 protein accumulation by IHC...
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladderR Røtterud
Department of Pathology, The Norwegian Radium Hospital, Montebello N 0310, Norway
BJU Int 88:202-8. 2001..To identify, in a retrospective study, possible molecular markers predictive of radioresponsiveness in patients with transitional cell carcinoma (TCC) of the bladder...
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU GroupS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
Br J Cancer 71:619-24. 1995..The HOP chemotherapy regimen is highly effective in patients with advanced metastatic seminoma or those relapsing after previous radiotherapy, but is associated with a high risk of toxicity, in particular myelotoxicity...
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007R Kvale
Department of Clinical and Registry based Research, The Cancer Registry of Norway, Oslo, Norway
Cancer Epidemiol 34:359-67. 2010....
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changesA Berg
Faculty Division The Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
Prostate Cancer Prostatic Dis 12:269-76. 2009..05) lower on physical function and vitality. Estimated free testosterone and measured serum estradiol had increased from baseline in most patients, but did not correlate with HRQoL outcomes 5 years after the start of treatment...
CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibilityW Kristiansen
Faculty of Health Sciences, Oslo University College, Oslo, Norway
Int J Androl 34:77-83. 2011..This study suggests that polymorphisms in the CYP1A1 gene may contribute to variability of individual susceptibility to TC...
Quality of life during radiotherapy for rectal cancerM G Guren
Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Eur J Cancer 39:587-94. 2003..HRQL scores had returned to pre-treatment levels 4-6 weeks after radiotherapy. Thus, diarrhoea, fatigue and appetite loss increased transiently during pelvic radiotherapy...
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian menW Kristiansen
Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences Department of Oncology, Oslo University Hospital Faculty of Medicine, University of Oslo, Oslo, Norway
Int J Androl 35:819-27. 2012..No statistically significant difference between the histological subtypes seminoma and non-seminoma was observed. Our results may suggest a possible association between genetic variation in the LHR gene and the risk of developing TC...
Long-term survivorship after cancer: how far have we come?S D Fossa
Department of Clinical Cancer Research, Rikshospitalet University Hospital and University of Oslo, Faculty of Medicine, Norwegian Radium Hospital, Oslo, Norway
Ann Oncol 19:v25-9. 2008
Sequential 5-fluorouracil and methotrexate. Negative experience in metastatic colorectal cancerE H Wanderas
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
Acta Oncol 26:289-93. 1987..The median survival was 7 months in group 1 and 10 1/2 months in group 2. Almost identical results were obtained by the two treatment schedules. The toxicity of both regimens was low...
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fossa
Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Montebello, Oslo
Br J Cancer 80:1392-9. 1999..The results of high-dose salvage chemotherapy should be interpreted on the background of these prognostic factors...
TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapyR Røtterud
Department of Pathology, The Norwegian Radium Hospital, Montebello, Oslo
Acta Oncol 40:644-52. 2001..We conclude that DNA aneuploidy may confer increased radiosensitivity in bladder cancer patients and that TP53 accumulation may confer increased radiosensitivity, but its effect is detectable only in euploid tumours...
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapyS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Montebello, Oslo
Br J Cancer 61:639-43. 1990..The application of the extended radiotherapy or the combination of radiotherapy and chemotherapy containing alkylating drugs should be avoided in order to reduce this excess risk...
High prostate cancer mortality in Norway: influence of Cancer Registry information?E Hernes
The Norwegian Radium Hospital HF, Montebello, Oslo, Norway
APMIS 113:542-9. 2005..7 to 22.9 per 100,000). In conclusion, the high rates of prostate cancer mortality in Norway could not be explained by information transfer from the CR to the COD Registry...
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urotheliumR Røtterud
The Urological Research Institute, Oslo Urological University Clinic, Aker University Hospital, Oslo, Norway
Histol Histopathol 22:349-63. 2007..EGFR and KAI1 may discriminate between non-metastasised and metastasised cancers. A complex network of associations between the factors is suggested...
Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapyW Lilleby
Department of Clinical Radiotherapy, The Norwegian Radium Hospital, The University of Oslo, Oslo, Norway
Cancer 92:311-9. 2001..The current study was conducted to evaluate and compare the impact of two major histologic grading systems on failure-free survival in patients with prostate carcinoma who are treated with definitive radiation...
[Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders]J Oldenburg
Department of Clinical Cancer Research, The Norwegian Radium Hospital, Montebello, 0310, Oslo, Norway
Urologe A 48:372-6. 2009..Furthermore, patients should be informed about long-term complications and their possible reduction by optimizing the risk factor profile...
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independenceE Hernes
Department of Clinical Cancer Research, The Norwegian Radium Hospital, Montebello, N 0310 Oslo, Norway
Br J Cancer 90:449-54. 2004..029). Our results support ongoing therapeutic attempts of EGFR inhibition in subgroups of patients with prostate cancer. Further research is needed to understand the function of EGFRs in this malignancy...
Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective studyS Johansen
Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, N 0310 Oslo, Norway
Radiat Oncol 6:68. 2011..To relate the development of post-treatment hypothyroidism with the dose distribution within the thyroid gland in breast cancer (BC) patients treated with loco-regional radiotherapy (RT)...
Androgen replacement and quality of life in patients treated for bilateral testicular cancerS D Fossa
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Montebello, Oslo, Norway
Eur J Cancer 35:1220-5. 1999..Schedules for ARP have to be improved. In spite of intermittent hypogonadism most patients are psychosocially and sexually well adjusted to their health situation...
A population-based study of spinal metastatic disease in South-East NorwayO Zaikova
Department of Oncological Surgery, Norwegian Radium Hospital, Oslo, Norway
Clin Oncol (R Coll Radiol) 21:753-9. 2009....
The level of physical activity in long-term survivors of testicular cancerL Thorsen
Department and Psychosocial Oncology and Rehabilitation, The Norwegian Radium Hospital, University of Oslo, Oslo 0310, Norway
Eur J Cancer 39:1216-21. 2003..32 (95% Confidence Interval (CI) 1.10-1.58)). The results indicate that the experience of testicular cancer increases rather than reduces the LPA in TCSs, independent of treatment given...
Health technology assessment and implications for clinical practice: the case of prostate cancer screeningI N Norderhaug
The Norwegian Centre for Health Technology Assessment, SINTEF Unimed, Oslo, Norway
Scand J Clin Lab Invest 63:331-8. 2003..In conclusion, evidence obtained through an international collaboration such as the INAHTA collaboration may be used to develop and implement national guidelines or recommendations...
Cancer patients' awareness about their diagnosis: a population-based studyC Nord
Department of Clinical Cancer Research, University Hospital, The Norwegian Radiumhospital, Montebello, N 0310 Oslo, Norway
J Public Health Med 25:313-7. 2003..The aim of the study was to evaluate Norwegian cancer patients' awareness of their prior cancer diagnosis in a general population-based study...
Late recurrences of germ cell malignancies: a population-based experience over three decadesJ Oldenburg
Faculty of Medicine, University of Oslo, Oslo, Norway
Br J Cancer 94:820-7. 2006..The 10-year incidence rate of late relapses of 1.3% might reflect the true incidence rate in a population-based cohort of MGCT patients, with cure in at least half of them...
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinomaM E Revheim
Division of Imaging and Intervention, Rikshospitalet, Oslo University Hospital, Oslo, Norway
Clin Oncol (R Coll Radiol) 23:339-43. 2011....
Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?H Magelssen
The Norwegian Radium Hospital, Dep of Clinical Research, Montebello, 0310 Oslo, Norway
Eur Urol 48:779-85. 2005..To evaluate the role of semen cryopreservation (SCP) in the fertility saving management of testicular cancer (TC) patients, treated at the Norwegian Radium Hospital between 1983 and 2002...
Familial testicular cancer in Norway and southern SwedenK Heimdal
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Br J Cancer 73:964-9. 1996..2% in familial TC and 13.3% in sporadic cases). This may indicate that different factors are of importance for the development of familial TC and UDT...
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancerC Nord
Department of Medical Oncology and Radiotherapy, University Hospital, The Norwegian Radium Hospital NRH, Oslo, Norway
Br J Cancer 88:36-41. 2003..Oncologists and young TCSs should be aware of the risk of excessive BMI increase, in particular, after the use of chemotherapy...
Post-treatment parenthood in Hodgkin's lymphoma survivorsC E Kiserud
Unit for long term outcome, Department of Clinical Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
Br J Cancer 96:1442-9. 2007..In univariate analyses, age at diagnosis was a significant factor related to post-treatment parenthood in females...
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancerA Fossa
Department of Immunology, The Norwegian Radium Hospital, Montebello, Oslo, 0310, Norway
Br J Cancer 83:743-9. 2000....
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancerB Smith-Sørensen
Department of Tumour Biology, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
Oncogene 21:8878-84. 2002..In summary, our data suggest that inactivation of MGMT contributes to development of nonseminomatous testicular cancer...
